Literature DB >> 23094960

Involvement of transcription factor Ets-1 in the expression of the α3 integrin subunit gene.

Go Kamoshida1, Ayaka Matsuda, Kouji Katabami, Takumi Kato, Hiromi Mizuno, Wakana Sekine, Teruaki Oku, Saotomo Itoh, Makoto Tsuiji, Yoshiyuki Hattori, Yoshie Maitani, Tsutomu Tsuji.   

Abstract

The α3β1 integrin is an adhesion receptor for extracellular matrix proteins, and plays crucial roles in cell motility, proliferation, and differentiation. The aberrant expression of this adhesion molecule on tumor cells is frequently associated with their malignant behaviors. We previously reported that the Ets transcription factor-binding consensus sequence 133 bp upstream of the mouse α3 integrin gene is an important element for its expression in various tumor cell lines. In the present study, we attempted to identify a transcription factor bound to the Ets-consensus sequence, and found that Ets-1 bound to this sequence in an electrophoretic mobility shift assay, chromatin immunoprecipitation assay, and pull-down assay with a tandem repeat of the sequence as adsorbent. We next examined the role of Ets-1 in α3 integrin gene expression by use of a luciferase assay with a reporter plasmid containing the 5'-flanking region of the α3 integrin gene. Cotransfection of HEK293T cells with an Ets-1 expression construct and the reporter plasmid increased luciferase activity. By contrast, transfection of HT1080 cells (high α3 integrin expresser) with a dominant-negative mutant of Ets-1 decreased luciferase activity. Overexpression of Ets-1 in HepG2 hepatocellular carcinoma cells (low α3 integrin expresser) upregulated α3 integrin expression as assessed by immunoprecipitation. Finally, the induction of α3 integrin gene expression in HepG2 cells after transforming growth factor-β1 treatment was abrogated by the dominant-negative mutant of Ets-1. These results suggest that Ets-1 is involved in transcriptional activation of the α3 integrin gene through its binding to the Ets-consensus sequence at -133 bp.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23094960     DOI: 10.1111/febs.12040

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  5 in total

1.  Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer.

Authors:  Anshu Aggarwal; Rami N Al-Rohil; Anupam Batra; Paul J Feustel; David M Jones; C Michael DiPersio
Journal:  BMC Cancer       Date:  2014-06-20       Impact factor: 4.430

2.  COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats.

Authors:  Lu Zhou; Sun Jung Yoon; Kyu Yun Jang; Young Jae Moon; Sajeev Wagle; Kwang Bok Lee; Byung-Hyun Park; Jung Ryul Kim
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

3.  The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer.

Authors:  Chong Li; Song Wu; Haifeng Wang; Xingang Bi; Zhao Yang; Ying Du; Luyun He; Zhiming Cai; Jiansong Wang; Zusen Fan
Journal:  Oncotarget       Date:  2015-08-14

4.  Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Naoko Kikkawa; Takayuki Arai; Atsushi Okato; Akira Kurozumi; Mayuko Kato; Koji Katada; Yoshitaka Okamoto; Naohiko Seki
Journal:  Cancer Sci       Date:  2017-07-04       Impact factor: 6.716

5.  miR-199a-5p regulates β1 integrin through Ets-1 to suppress invasion in breast cancer.

Authors:  Wentong Li; Hui Wang; Jinbao Zhang; Limin Zhai; Weijuan Chen; Chunling Zhao
Journal:  Cancer Sci       Date:  2016-06-13       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.